Updates in the Management of Stage III Non-Small Cell Lung Cancer (NSCLC)

Medical experts discuss a specific case for a patient diagnosed with stage IIIB NSCLC.

Panelists discuss the utilization of testing and multidisciplinary approaches for testing.

The panel discusses a variety of clinical trials and the impact on patient treatment in early stage NSCLC.

A variety of treatment options in ES NSCLC are explored by key opinion leaders.

The panel discusses reassessing for respectability after certain treatments.

The panel discusses management of resectable early-stage non–small cell lung cancer.

The panel discusses the factors that go into selecting patients for adjuvant therapy.

The panel looks at a second patient case study.

The panel discusses data necessary for selecting patients with unrespectable non–small cell lung cancer for sequential vs concurrent chemoradiotherapy.

The panel discusses treatment considerations for consolidation durvalumab.